你好!欢迎访问 登录|立即注册

0576-88813233

|
当前位置:科瑞产品

英夫利昔单抗 Infliximab

英夫利昔单抗 Infliximab 170277-31-3
规格 价格 库存 数量
在线咨询 大包装询价 加入购物车
如您需要更多数量的报价,请点击立即获取报价或者通过电子邮件sales@crene.cn把您需要的数量信息提交给我们我们会在第一时间回复您,谢谢!
产品信息
产品名称:英夫利昔单抗 Infliximab 纯度:99% min
CAS NO:170277-31-3 溶解度:
分子式:C6428H9912N1694O1987S46 包装:可按客户要求包装
分子量:144190.3 g/mol 贮存:-20℃
质量控制
备注说明

Infliximab is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat autoimmune diseases. Infliximab was approved by the U.S. Food and Drug Administration (FDA) for the treatment of Crohn's disease, ulcerative colitis, psoriasis, psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis.It is used off-label outside its FDA approval for Behçet's disease and other conditions. Infliximab is administered by intravenous infusion, typically at six- to eight-week intervals. It cannot be given by mouth because the digestive system would destroy the drug.

参考文献

版权所有 Copyright(C) 2018-2024 台州市科瑞生物技术有限公司

技术支持:kerui  浙ICP备09021343号-1
公司所列产品中涉及到专利,只供研发使用,不做销售;管制产品将严格遵守中国法律和购买客户国法律的规定销售,所有产品都不适用于人用 如被销售到构成专利侵权的国家,则相应的一切风险将由买方承担。